Alflutinib 是EGFR抑制剂。 它对 T790M 的性耐药突变以及 EGFR 活性突变具有抑制作用。它对于癌症疾病，特别是非小细胞肺癌(NSCLC)方面具有研究潜力。

Alflutinib is an inhibitor of EGFR, and its targets including EGFR activating mutations and T790M, thus leading to tumor growth inhibition.

1869057-83-9

C28H31F3N8O2

568.59

AST2818;ASK120067

DMSO:10.83 mg/ml (19.05 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years